Patient Portal

Jeff M. Michalski, MD, MBA

Professor, Radiation Oncology
Vice Chairman, Radiation Oncology
Chief, Genitourinary Service

Specialty Areas

Radiation Oncology
Genitourinary Oncology
Sarcoma
Prostate Cancer
Intensity Modulated Radiation Therapy ( IMRT)
Pediatric Radiation Oncology

Board Certifications

Radiation Oncology

Hospital Affiliations

Barnes-Jewish Hospital
St. Louis Children's Hospital
Christian Hospital
Barnes-Jewish West County Hospital
VA Medical Center - St. Louis - John Cochran Division

Areas of Clinical Interest

Radiation therapy, radiation oncology, pediatric oncology, prostate conditions, prostate cancer, treatment planning, carcinoma of the prostate, conformal radiation therapy, prostate brachytherapy

  • Maps & Directions
  • Education
  • Publication & Research

Maps & Directions

Maps & Directions

Center for Advanced Medicine
Siteman Cancer Center

4921 Parkview Place
St. Louis, MO 63110

Floor: LL
Office Phone: 314-747-7236
Fax: 314-747-9557

Christian Hospital

1133 Dunn Road
St. Louis, MO 63136

Office Phone: 314-653-5255
Fax: 314-653-4283

Siteman Cancer Center - South County

5225 MidAmerica Plaza
St. Louis, MO 63129

Education

Education

Instructor - Fellow: Washington University School of Medicine, Radiation Oncology Center, St. Louis, MO 1991
Resident: Radiation Oncology, Washington University School of Medicine, St. Louis, MO. 1990
Resident: Radiation Oncology, Columbia-Presbyterian Medical Center 1988
Medical Degree: Medical College Of Wisconsin 1986
B.S. Biochemistry: University of Wisconsin-Madison 1982

Publication & Research

Publication & Research

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.
Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR Jr, Shipley WU, Sandler HM
Lancet Oncol. 2018 Oct 10; pii: S1470-2045(18)30528-X. doi: 10.1016/S1470-2045(18)30528-X.

PMID:
    30316827
    [PubMed - as supplied by publisher]
Related citations


Radiation Therapy for Prostate Cancer.
Gay HA, Michalski JM
Mo Med. 2018 Mar-Apr; 115(2)146-150.

PMID:
    30228707
    [PubMed - in process]
Related citations


Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities.
Xiao C, Moughan J, Movsas B, Konski AA, Hanks GE, Cox JD, Roach M 3rd, Zeitzer KL, Lawton CA, Peters CA, Rosenthal SA, Hsu IJ, Horwitz EM, Mishra MV, Michalski JM, Parliament MB, D'Souza DP, Pugh SL, Bruner DW
Adv Radiat Oncol. 2018 Jul-Sep; 3(3)405-411. doi: 10.1016/j.adro.2018.04.010.

PMID:
    30202809
    [PubMed]
Related citations


Palliative radiation therapy (RT) for prostate cancer patients with bone metastases at diagnosis: A hospital-based analysis of patterns of care, RT fractionation scheme, and overall survival.
Fischer-Valuck BW, Baumann BC, Apicelli A, Rao YJ, Roach M, Daly M, Dans MC, White P, Contreras J, Henke L, Gay H, Michalski JM, Abraham C
Cancer Med. 2018 Sep; 7(9)4240-4250. doi: 10.1002/cam4.1655.

PMID:
    30120817
    [PubMed - in process]
Related citations


Responses of the Human Gut <i>Escherichia coli</i> Population to Pathogen and Antibiotic Disturbances.
Richter TKS, Michalski JM, Zanetti L, Tennant SM, Chen WH, Rasko DA
mSystems. 2018 Jul-Aug; 3(4)pii: e00047-18. doi: 10.1128/mSystems.00047-18.

PMID:
    30057943
    [PubMed]
Related citations


Intensity-modulated radiotherapy for prostate cancer.
Fischer-Valuck BW, Rao YJ, Michalski JM
Transl Androl Urol. 2018 Jun; 7(3)297-307. doi: 10.21037/tau.2017.12.16.

PMID:
    30050791
    [PubMed]
Related citations


Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer.
Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M 3rd, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA
Int J Radiat Oncol Biol Phys. 2018 Oct 1; 102(2)287-295. doi: 10.1016/j.ijrobp.2018.06.008.

PMID:
    29913254
    [PubMed - in process]
Related citations


Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung Cancer.
Timmerman RD, Hu C, Michalski JM, Bradley JC, Galvin J, Johnstone DW, Choy H
JAMA Oncol. 2018 Sep 1; 4(9)1287-1288. doi: 10.1001/jamaoncol.2018.1258.

PMID:
    29852036
    [PubMed - in process]
Related citations


Practical Implications of Ferromagnetic Artifacts in Low-field MRI-guided Radiotherapy.
Green O, Henke LE, Parikh P, Roach MC, Michalski JM, Gach HM
Cureus. 2018 Mar 22; 10(3)e2359. doi: 10.7759/cureus.2359.

PMID:
    29805928
    [PubMed]
Related citations


Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Luh JY, Finkelstein SE, Michalski JM, Sandler H
Ann Intern Med. 2018 Apr 17; 168(8)607-608. doi: 10.7326/L17-0734.

PMID:
    29677258
    [PubMed - in process]
Related citations


Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM, Moughan J, Purdy J, Bosch W, Bruner DW, Bahary JP, Lau H, Duclos M, Parliament M, Morton G, Hamstra D, Seider M, Lock MI, Patel M, Gay H, Vigneault E, Winter K, Sandler H
JAMA Oncol. 2018 Jun 14; 4(6)e180039. doi: 10.1001/jamaoncol.2018.0039.

PMID:
    29543933
    [PubMed - in process]
Related citations


Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy.
Acharya S, Robinson CG, Michalski JM, Mullen D, DeWees TA, Campian JL, Chundury A, Bottani B, Hallahan DE, Bradley JD, Huang J
Int J Radiat Oncol Biol Phys. 2018 Jun 1; 101(2)334-343. doi: 10.1016/j.ijrobp.2018.01.099.

PMID:
    29534896
    [PubMed - in process]
Related citations


NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ Jr
J Neurooncol. 2018 Mar; 137(1)39-47. doi: 10.1007/s11060-017-2558-x.

PMID:
    29404979
    [PubMed - in process]
Related citations


Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA
JAMA Oncol. 2018 May 10; 4(5)e175230. doi: 10.1001/jamaoncol.2017.5230.

PMID:
    29372236
    [PubMed - in process]
Related citations


A multi-institutional phase 2 trial of prostate stereotactic body radiation therapy (SBRT) using continuous real-time evaluation of prostate motion with patient-reported quality of life.
Jackson WC, Dess RT, Litzenberg DW, Li P, Schipper M, Rosenthal SA, Chang GC, Horwitz EM, Price RA, Michalski JM, Gay HA, Wei JT, Feng M, Feng FY, Sandler HM, Wallace RE, Spratt DE, Hamstra DA
Pract Radiat Oncol. 2018 Jan - Feb; 8(1)40-47. doi: 10.1016/j.prro.2017.08.004.

PMID:
    29304991
    [PubMed - indexed for MEDLINE]
Related citations


Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.
Ramey SJ, Agrawal S, Abramowitz MC, Moghanaki D, Pisansky TM, Efstathiou JA, Michalski JM, Spratt DE, Hearn JWD, Koontz BF, Liauw SL, Pollack A, Anscher MS, Den RB, Stephans KL, Zietman AL, Lee WR, Stephenson AJ, Tendulkar RD
Eur Urol. 2018 Jul; 74(1)99-106. doi: 10.1016/j.eururo.2017.10.009.

PMID:
    29128208
    [PubMed - in process]
Related citations


Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder.
Fischer-Valuck BW, Rao YJ, Henke LE, Rudra S, Hui C, Baumann BC, Gay HA, Michalski JM
Eur Urol Focus. 2017 Sep 14; pii: S2405-4569(17)30205-5. doi: 10.1016/j.euf.2017.09.001.

PMID:
    28919521
    [PubMed - as supplied by publisher]
Related citations


Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer: American Urological Association/American Society of Clinical Oncology/American Society for Radiation Oncology/Society of Urologic Oncology Clinical Practice Guideline Summary.
Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM
J Oncol Pract. 2017 Sep; 13(9)621-625. doi: 10.1200/JOP.2017.024919.

PMID:
    28796558
    [PubMed - in process]
Related citations


Thrombotic Thrombocytopenic Purpura (TTP)
Stanley M, Michalski JM
. 2018 Jan;

PMID:
    28613472
    [PubMed]
Related citations


External Beam Radiation Therapy or Brachytherapy With or Without Short-course Neoadjuvant Androgen Deprivation Therapy: Results of a Multicenter, Prospective Study of Quality of Life.
Gay HA, Sanda MG, Liu J, Wu N, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal CS, Litwin MS, Kuban DA, Hembroff L, Regan MM, Chang P, Prostate Cancer Outcomes and Satisfaction with Treatment Quality Assessment Consortium., Michalski JM
Int J Radiat Oncol Biol Phys. 2017 Jun 1; 98(2)304-317. doi: 10.1016/j.ijrobp.2017.02.019.

PMID:
    28463150
    [PubMed - indexed for MEDLINE]
Related citations